Outcomes with guideline-directed medical therapy and cardiac implantable electronic device therapies for patients with heart failure with reduced ejection fraction

By sjmartinez • April 2, 2024

Mignone JL, Alexander KM, Dobbles M, Eberst K, Fonarow GC, Ellenbogen KA. Outcomes with guideline-directed medical therapy and cardiac implantable electronic device therapies for patients with heart failure with reduced ejection fraction. Heart Rhythm O2. 2024 Jan 24;5(3):168-173. doi: 10.1016/j.hroo.2024.01.004. PMID: 38560378; PMCID: PMC10980920.

Tags: cardiac resynchronization therapy, Cardiology/Epi, Guideline-directed medical therapy, Heart failure with reduced ejection fraction, Implantable cardioverter-defibrillators, Publications, Therapy optimization

Management and Surveillance of Immune Checkpoint Inhibitor Myocarditis: Managing the Aftermath: JACC CardioOncology State-of-the-Art Review

Morad TT, Keykhaei M, Terraciano DA, Srivastava PK, Yang EH, Stein-Merlob AF. Management and Surveillance of Immune Checkpoint Inhibitor Myocarditis: Managing the Aftermath: JACC CardioOncology[...]

Interrelationships Between Kansas City Cardiomyopathy Questionnaire Domains, Age, and Sex for Patients With Heart Failure: Findings From the CHAMP-HF and CORC Registries

Girard AA, Jones PG, Fu Z, Sherrod CF 4th, Cantu Martinez O, Greene SJ, Bachmann JM, Fonarow GC, Butler J, Spertus JA, Arnold SV. Interrelationships[...]

Patient-Level Perivascular Adipose Tissue Density Aggregation and Plaque Progression: Plaque-Free vs Plaque-Adjacent Segments

Lee SE, Sung JM, Andreini D, Al-Mallah MH, Budoff MJ, Cademartiri F, Chinnaiyan K, Choi JH, Chun EJ, Conte E, Gottlieb I, Hadamitzky M, Kim[...]